Avience Biomedicals Ltd IPO - Check Issue Date, Price, Lot Size & Details with BlinkX.

Avience Biomedicals Ltd IPO

Recognized under the Make in India Mission initiated by Prime Minister Narendra Modi, The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, HIV, HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good quality solutions. Avience Biomedicals has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs.

Avience Biomedicals Ltd IPO Details

Total Shares Offered

₹ 14,53,800

Offer to Public

TBA

Retail Max (Shares)

₹ 4,81,200

Pre Issue Promoters Holding

₹ 35,42,885

Exchange

DBC

Issue size

₹ 30.24 Cr

IPO Open Date

Jun 18, 2026

Close Date

Jun 22, 2026

Lot Size

1200

Min Investment

₹ 2,35,200

Issue Type

Book Building - SME

Listing Date

Jun 25, 2026

Avience Biomedicals Ltd IPO Dates

Jun 18, 2026

Opening date

Jun 22, 2026

Closing date

Jun 23, 2026

Basis of Allotment

Jun 24, 2026

Initiation of Refunds

Jun 24, 2026

Credit of Shares

Jun 25, 2026

Listing date

Details

Sector	Type
Sector	Trading
Sub Sector	NA
Issue Type	Book Building - SME

Subscription Status

*Values are in Lakhs

Investor Type	Subscription Times	Shares Offered*
QIB	0x	683400
NII	0x	207000
Retail	0x	481200
Employee	0x	0
Total	0x	1453800

Investor Type

QIB

NII

Retail

Employee

Total

Subscription Times

683400

207000

481200

1453800

Avience Biomedicals Ltd Financial Status

Income Statement

Particulars (In Rs. Crores)

Balance Sheet

Particulars (In Rs. Crores)

Particulars (in Rs. Crores)	FY23	FY22	FY21
Revenue from operations	45.24	23.96	1.17
EBITDA	8.36	3.63	1.37
PAT	5.00	2.00	0.78
Total Assets	23.26	12.19	6.89
Share Capital	4.03	3.28	3.28
Total Borrowings	11.92	6.27	3.91
Operating Activities (Net Cash)	5.75	2.44	0.98
Investing Activities (Net Cash)	1.11	5.70	0.00
Financing Activities (Net Cash)	11.92	6.27	3.91
Net Cashflow	4.75	0.20	0.40

About Avience Biomedicals Ltd

Our Company was incorporated as Avience Biomedicals Private Limited under the provisions of the Companies Act, 2013 vide certificate of incorporation dated December 23, 2019, in Delhi. Subsequently, our Company was converted into a Public Limited Company pursuant to Shareholders Resolution passed at the Extra Ordinary General Meeting of the Company held on June 26, 2024 and the name of our Company was changed from Avience Biomedicals Private Limited to Avience Biomedicals Limited vide a fresh Certificate of Incorporation dated September 03, 2024 having CIN U74999DL2019PLC359158 issued by the Registrar of Companies, Central Processing Centre, Delhi. The registered office of our company is situated at C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi-110058, India.

The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry. Major segments of Indian Pharmaceutical Industry include diagnostic kits, medical devices etc. The healthcare and medical device sectors in India have grown significantly in the last decade. A wide range of medical devices, from consumables to implantable medical devices, are produced in India. Most medical devices manufactured in India are biochemistry analyser, Reagents, devices related to hematology and immunology etc. The medical devices sector is highly capital intensive and requires continuous training of the healthcare system providers to adapt to new technologies. The Indian laboratory diagnostics industry, estimated at USD 18.5 billion, is growing at a healthy rate of 13-14% per annum. Currently there are more than 1 lakh labs across the country, offering a wide range of tests (up to 4500). The Indian industry operates at one of the lowest price points in the world. The costs are around one-eighth those in the US. Even at these low rates, the Indian medical diagnostics industry has been able to provide people living in remote areas access to modern diagnostics facilities.

Peer Comparison:

No listed in Industry Peers

Avience Biomedicals Ltd Key Points

Strengths

Experienced Management Team and trained Employees.

Optimal Utilization of Resources.

Quality assurance and control.

Cordial relationships with our clients.

Risk

The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose us to litigation or other liabilities, which could adversely affect our reputation, business, financial condition and results of operations.

We are dependent on certain customers for a portion of our revenues. The loss of any of our major customers due to any adverse development or significant reduction in business from our major customers may adversely affect our business, financial condition, results of operations and future prospects.

We rely on suppliers for medical devices and equipment manufacturers for our trading goods, and also face risks in sourcing raw materials and components from third parties for the manufacturing and assembly of our medical equipment. Any disruption in the supply of these goods or materials could adversely impact our business, operations, and financial condition.

Strategy

Market Analysis.

Product Portfolio Strategy.

Research and Development.

Operational Excellence.

Quality Assurance and Regulatory Compliance.

How To Apply for Avience Biomedicals Ltd IPO Online?

Step 1:

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

FAQs on IPO (Initial Public Offering)

What is the issue size of the Avience Biomedicals Ltd IPO?

Avience Biomedicals Ltd's IPO offers shares for up to 30.24 It begins on Jun 18, 2026 and ends on Jun 22, 2026.

What is the price of the Avience Biomedicals Ltd IPO?

The price of Avience Biomedicals Ltd IPO ranges between ₹196 to ₹208 per share.

What are the open and close dates for the Avience Biomedicals Ltd IPO?

The Avience Biomedicals Ltd IPO opens on Jun 18, 2026 and closes on Jun 22, 2026.

When will the Avience Biomedicals Ltd IPO be allotted?

The allotment for the Avience Biomedicals Ltd IPO will be finalised on Jun 23, 2026. The shares will be listed on BSE and NSE on Jun 25, 2026.

What is the minimum lot size required for Avience Biomedicals Ltd IPO?

The minimum lot size for Avience Biomedicals Ltd IPO is 1200 shares, priced between ₹196 to ₹208 per share.

What is the GMP of Avience Biomedicals Ltd IPO?

The GMP (Grey Market Premium) of Avience Biomedicals Ltd IPO fluctuates based on market demand and sentiment.

How do you check the allotment status of Avience Biomedicals Ltd IPO?

To check the allotment status of Avience Biomedicals Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

Where is the Avience Biomedicals Ltd IPO getting listed?

The Avience Biomedicals Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Jun 18, 2026, and closes on Jun 22, 2026. The allotment is finalised on Jun 23, 2026.

How do you apply for the Avience Biomedicals Ltd IPO?

To apply for the Avience Biomedicals Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.